Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

著者: Shah, Ami N, Flaum, Lisa, Helenowski, Irene, Santa-Maria, Cesar A, Jain, Sarika, Rademaker, Alfred, Nelson, Valerie, Tsarwhas, Dean, Cristofanilli, Massimo, Gradishar, William
出版年 J Immunother Cancer (2020)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

著者: Davis, Andrew A., Zhang, Qiang, Gerratana, Lorenzo, Shah, Ami N., Zhan, Youbin, Qiang, Wenan, Finkelman, Brian S., Flaum, Lisa, Behdad, Amir, Gradishar, William J., Platanias, Leonidas C., Cristofanilli, Massimo
出版年 Breast Cancer Res (2019)

Landscape of circulating tumour DNA in metastatic breast cancer

著者: Davis, Andrew A., Jacob, Saya, Gerratana, Lorenzo, Shah, Ami N., Wehbe, Firas, Katam, Neelima, Zhang, Qiang, Flaum, Lisa, Siziopikou, Kalliopi P., Platanias, Leonidas C., Gradishar, William J., Behdad, Amir, Cristofanilli, Massimo
出版年 EBioMedicine (2020)

A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

著者: Santa-Maria, Cesar August, Kato, Taigo, Park, Jae-Hyun, Kiyotani, Kazuma, Rademaker, Alfred, Shah, Ami N., Gross, Leeaht, Blanco, Luis Z., Jain, Sarika, Flaum, Lisa, Tellez, Claudia, Stein, Regina, Uthe, Regina, Gradishar, William J., Cristofanilli, Massimo, Nakamura, Yusuke, Giles, Francis J.
出版年 Oncotarget (2018)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer

著者: Gerratana, Lorenzo, Davis, Andrew A., Zhang, Qiang, Basile, Debora, Rossi, Giovanna, Strickland, Kimberly, Franzoni, Alessandra, Allegri, Lorenzo, Mu, Zhaomei, Zhang, Youbin, Flaum, Lisa E., Damante, Giuseppe, Gradishar, William John, Platanias, Leonidas C., Behdad, Amir, Yang, Hushan, Puglisi, Fabio, Cristofanilli, Massimo
出版年 JCO Precis Oncol (2021)